natgillin/translations-raw huggingface dataset:
Although there is no evidence of rebound seizures with gabapentin, abrupt withdrawal of anticonvulsants in epileptic patients may precipitate status epilepticus (see section 4.2). 
Čeprav pri dajanju gabapentina ni dokazov o povratnih, ponavljajočih se napadih, lahko nenadna prekinitev antikonvulzivov pri epileptičnih bolnikih sproži status epilepticus (glejte poglavje 4.2).
• Incontinence 
• inkontinenca
Pfizer Hellas A.E., Alketou 5, 11633 Athens Greece 
Pfizer Hellas A.E., Alketou 5, 11633 Athens Grčija
Ae% = Percent of dose excreted unchanged into the urine from time 0 to 8 hours postdose 
Ae% = odstotek odmerka, ki se je nespremenjen izločil v urinu od 0 do 8 ur po odmerku NP = ni podatka
Based on the available information and a literature search, no major safety issue seems to be associated with the administration of gabapentin. 
Na podlagi dostopnih podatkov in pregleda literature ni mogoče najti večjih zadržkov glede varnosti, ki bi bili povezani z uporabo gabapentina.
Like all medicines, [Neurontin and associated names] can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi zdravilo [Neurontin in povezana imena] neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
In addition, the clinical data support of the starting dose, the titration schedule, and the maximum total daily dosage of 3600 mg administered in three doses. 
Poleg tega klinični podatki podpirajo začetni odmerek, razpored titracije in največji skupni dnevni odmerek 3600 mg, ki se razdeli v tri odmerke.
For renally impaired patients undergoing haemodialysis, the maintenance dose of gabapentin should be based on the dosing recommendations found in Table 2. 
Pri bolnikih z okvaro ledvic, ki so na hemodializi, mora vzdrževalni odmerek gabapentina temeljiti na priporočilih za odmerjanje, navedenih v tabeli 2.
• Severe skin reactions that require immediate medical attention, swelling of the lips and face, skin rash and redness, hair loss 
• hude kožne reakcije, ki zahtevajo takojšnjo zdravniško oskrbo, otekanje ustnic in obraza, izpuščaj in pordelost kože, izpadanje las in dlak
The total daily dose should be divided in three single doses, the maximum time interval between doses should not exceed 12 hours. 
Celotni dnevni odmerek je treba razdeliti v tri posamične odmerke, najdaljši presledek med odmerki pa ne sme preseči 12 ur.
Epilepsy: 
Epilepsija:
the CHMP has recommended amendments of the Summary of Products Characteristic, Labelling and Package Leaflet, as set out in Annexe III of the CHMP opinion for Neurontin and associated names (see Annexe I of the opinion). 
CHMP priporoča dopolnitev Povzetka glavnih značilnosti zdravila, označevanja in Navodil za uporabo, kakor je opredeljeno v Dodatku III Mnenja CHMP za zdravilo Neurontin in povezana imena (glejte Dodatek I Mnenja).
Because the effect on the nursing infant is unknown, it is not recommended to breast-feed your baby while using [Neurontin and associated names]. 
Ker učinek na dojenega otroka ni znan, dojenje med uporabo zdravila [Neurontin in povezana imena] ni priporočljivo.
Gabapentin is not considered effective against primary generalized seizures such as absences and may aggravate these seizures in some patients. 
Gabapentin ne velja za učinkovitega proti primarnim generaliziranim napadom, npr. absencam; pri nekaterih bolnikih lahko takšne napade celo poslabša.
Gabapentin partially reduces responses to the glutamate agonist N-methyl-D-aspartate (NMDA) in some test systems in vitro, but only at concentrations greater than 100 µM, which are not achieved in vivo. 
Gabapentin v nekaterih testnih sistemih in vitro delno zmanjša odzive na glutamatni agonist N-metil-Daspartat (NMDA), vendar le v koncentracijah nad 100µM, ki pa in vivo niso dosežene.
300 mg two times a day 300 mg three times a day 
300 mg enkrat na dan 300 mg dvakrat na dan
• Blurred vision, double vision 
• zamegljen vid, dvojen vid
Gabapentin bioavailability (fraction of dose absorbed) decreases with increasing dose which imparts non-linearity to pharmacokinetic parameters which include the bioavailability parameter (F) e.g. Ae%, CL/F, Vd/F. 
Biološka uporabnost gabapentina (delež absorbiranega odmerka) se s povečevanjem odmerka zmanjšuje, kar povzroči nelinearnost farmakokinetičnih parametrov, ki vključujejo parameter biološke uporabnosti (F), npr. Ae%, CL/F, Vd/F.
This product contains lactose monohydrate. 
Zdravilo vsebuje monohidrat laktoze.
PHARMACEUTICAL FORM Capsule, hard 
FARMACEVTSKA OBLIKA Trde kapsule
If [Neurontin and associated names] and antacids containing aluminium and magnesium are taken at the same time, absorption of [Neurontin and associated names] from the stomach may be reduced. 
Če zdravilo [Neurontin in povezana imena] vzamete hkrati z antacidi, ki vsebujejo aluminij ali magnezij, se lahko absorpcija zdravila [Neurontin in povezana imena] iz prebavil zmanjša.
Take the number of capsules or tablets as instructed by your doctor. 
Vzemite toliko kapsul oz. tablet, kot vam je naročil zdravnik.
Gabapentin is structurally related to the neurotransmitter GABA (gamma-aminobutyric acid) but the precise mechanism of action of gabapentin is not yet known. 
Gabapentin je strukturno soroden nevrotransmitorju GABA (gama-aminomaslena kislina), vendar njegov natančen mehanizem delovanja še ni znan.
The absence of adequate long term studies (more than 36 weeks) in children to assess growth, learning, intelligence, and development in children and adolescents, is mentioned in section 4.4. 
V poglavju 4.4 je omenjena odsotnost zadostnih dolgoročnih raziskav (ki trajajo dlje kot 36 tednov) pri otrocih za vrednotenje rasti, učenja, inteligence in razvoja otrok in mladostnikov.
In animals, gabapentin readily enters the brain and prevents seizures from maximal electroshock, from chemical convulsants including inhibitors of GABA synthesis, and in genetic models of seizures. 
Pri živalih gabapentin zlahka prestopa v možgane in preprečuje konvulzije zaradi maksimalnega elektrošoka, zaradi kemičnih konvulzivov (vključno z zaviralci sinteze GABA) in v genetskih modelih konvulzij.
The total daily dose should be divided in three single doses, the maximum time interval between the doses should not exceed 12 hours to prevent breakthrough convulsions. 
Celotni dnevni odmerek je treba razdeliti v tri posamične odmerke, najdaljši presledek med odmerki pa ne sme preseči 12 ur, da bi preprečili občasne, nenadne konvulzije.
impotence 
impotenca
In clinical trials, the effective dosing range was 900 to 3600 mg/day. 
V kliničnih preskušanjih je bil učinkovit razpon odmerkov od 900 do 3600 mg/dan.
Gabapentin does not induce hepatic mixed function oxidase enzymes responsible for drug metabolism. 
Gabapentin ne inducira jetrnih oksidaznih encimov mešane funkcije, odgovornih za presnovo zdravil.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER {Name and Address} <{tel}> <{fax}> <{e-mail}> [See Annex I - To be completed nationally] 
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM {Ime in naslov} <{tel.}> <{faks}> <{e-pošta}> [Glejte Dodatek I - Izpolni država članica]
c For patients with creatinine clearance <15 ml/min, the daily dose should be reduced in proportion to creatinine clearance (e.g., patients with a creatinine clearance of 7.5 ml/min should receive one-half the daily dose that patients with a creatinine clearance of 15 ml/min receive). 
b Uporabite po 300 mg vsak drugi dan. c Bolnikom z očistkom kreatinina < 15 ml/min je treba dnevni odmerek zmanjšati sorazmerno očistku kreatinina (tako morajo npr. bolniki z očistkom kreatinina 7,5 ml/min dobivati polovico tistega dnevnega odmerka, ki ga dobivajo bolniki z očistkom kreatinina 15 ml/min).
Sudden unexplained deaths have been reported where a causal relationship to treatment with gabapentin has not been established. 
Poročali so o nenadnih nepričakovanih smrtih, vendar vzročna povezanost s terapijo z gabapentinom ni bila ugotovljena.
Regarding epilepsy, the indication as adjunctive therapy in children aged 3 years and above as well as the indication as monotherapy were debated. 
V zvezi z epilepsijo so razpravljali o indikaciji dodatnega zdravljenja pri otrocih, starih 3 leta in več, ter o indikaciji monoterapije.
Alternatively, the starting dose is 900 mg/day given as three equally divided doses. 
Druga možnost je uporaba začetnega odmerka 900 mg/dan v treh enakih deljenih odmerkih.
No definite conclusion can be made as to whether gabapentin is associated with an increased risk of congenital malformations when taken during pregnancy, because of epilepsy itself and the presence of concomitant antiepileptic medicinal products during each reported pregnancy. 
Ni mogoče zanesljivo sklepati, ali med nosečnostjo uporabljeni gabapentin predstavlja večje tveganje za prirojene malformacije zaradi same epilepsije in dejstva, da so bila med vsako nosečnostjo, o kateri so poročali, prisotna tudi druga antiepileptična zdravila.
Gabapentin is eliminated unchanged solely by renal excretion. 
Gabapentin se eliminira nespremenjen, zgolj z izločanjem skozi ledvice.
Gabapentin can be given with or without food and should be swallowed whole with sufficient fluidintake (e.g. a glass of water). 
Pogoltniti ga je treba celega in z zadostno količino tekočine (npr. s kozarcem vode).
Additional post-hoc analyses of the responder rates by age did not reveal a statistically significant effect of age, either as a continuous or dichotomous variable (age groups 3-5 and 6-12 years). 
Dodatne post-hoc analize stopnje odziva po starosti niso pokazale statistično pomembnega učinka starosti niti za zvezno spremenljivko niti za dihotomno spremenljivko (starostni skupini 3-5 in 6-12 let).
No systematic studies in patients 65 years or older have been conducted with gabapentin. 
Z gabapentinom niso izvedli sistematičnih študij pri bolnikih, starih 65 let ali več.
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 
DODATEK I SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, POTI UPORABE ZDRAVILA, PREDLAGATELJEV, IMETNIKOV DOVOLJENJA ZA PROMET Z ZDRAVILOM V DRŽAVAH ČLANICAH
There have been no studies specifically looking at the use of gabapentin in pregnant women, but other medications used to treat seizures have reported an increased risk of harm to the foetus, particularly when more than one seizure medication is taken at the same time. 
Posebnih študij uporabe gabapentina pri nosečnicah ni bilo, vendar je za druga zdravila za zdravljenje epilepsije opisano, da povečujejo tveganje za škodljive učinke na plod, zlasti ob sočasnem jemanju več kot enega zdravila za zdravljenje epilepsije.
No significant issues relating to quality were identified and the pharmaceutical particulars of the product information were completed, except for the sections to be completed nationally. 
Farmacevtski podatki v informacijah o zdravilu so bili dopolnjeni, razen poglavij, ki se izpolnijo na nacionalni ravni.
If your treatment is stopped it should be done gradually over a minimum of 1 week. 
Če se zdravljenje konča, je treba odmerek zdravila zmanjševati postopoma, najmanj 1 teden.
In one double blind study in patients with neuropathic pain, somnolence, peripheral oedema and asthenia occurred in a somewhat higher percentage in patients aged 65 years or above, than in younger patients. 
V eni dvojno slepi študiji bolnikov z nevropatskimi bolečinami so se pri bolnikih, starih 65 let ali več, somnolentnost, periferni edemi in astenija pojavili nekoliko pogosteje kot pri mlajših bolnikih.
If a patient develops acute pancreatitis under treatment with gabapentin, discontinuation of gabapentin should be considered (see section 4.8). 
Če se bolniku med zdravljenjem z gabapentinom pojavi akutni pankreatitis, morate razmisliti o prekinitvi te terapije (glejte poglavje 4.8).
It is therefore recommended that [Neurontin and associated names] is taken at the earliest two hours after taking an antacid. 
Zato je priporočljivo, da zdravilo [Neurontin in povezana imena] vzamete najmanj dve uri potem, ko ste vzeli antacid.
Gabapentin elimination-rate constant, plasma clearance, and renal clearance are directly proportional to creatinine clearance. 
Konstanta hitrosti eliminacije, plazemski očistek in ledvični očistek gabapentina so neposredno sorazmerni očistku kreatinina.
In elderly patients, and in patients with impaired renal function, gabapentin plasma clearance is reduced. 
Pri starejših bolnikih in bolnikih z okvarjenim delovanjem ledvic je plazemski očistek gabapentina manjši.
Gabapentin bioavailability (fraction of dose absorbed) tends to decrease with increasing dose. 
Biološka uporabnost gabapentina (delež absorbiranega odmerka) se s povečevanjem odmerka zmanjšuje.
Coadministration of gabapentin with oral contraceptives containing norethindrone and/or ethinyl estradiol, does not influence the steady-state pharmacokinetics of either component. 
Sočasna uporaba gabapentina s peroralnimi kontraceptivi, ki vsebujejo noretindron in/ali etinilestradiol, v stanju dinamičnega ravnovesja ne vpliva na farmakokinetiko nobene od teh sestavin.
Pfizer Oy, Tietokuja 4 00330 Helsinki Finland 
Pfizer Oy, Tietokuja 4 00330 Helsinki Finska
For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. 
Shema titriranja pri uvedbi terapije za vse indikacije je prikazana v tabeli 1; priporočena je za odrasle in mladostnike, stare 12 let in več.
Peripheral neuropathic pain: [Neurontin and associated names] is used to treat long lasting pain caused by damage to the nerves. 
Periferne nevropatske bolečine: zdravilo [Neurontin in povezana imena] uporabljamo za zdravljenje dolgotrajnih bolečin, ki jih povzroči okvara živcev.
Where an adverse reaction was seen at different frequencies in clinical studies, it was assigned to the highest frequency reported. 
Če se je pogostnost neželenega učinka med kliničnimi študijami razlikovala, je zabeležen pri največji opisani pogostnosti.
• Blood glucose fluctuations in patients with diabetes, abnormal blood test results suggesting problems with the liver. 
• nihanje ravni glukoze v krvi pri diabetikih, nenormalni izvidi krvnih preiskav, ki kažejo na težave z jetri.
[Neurontin and associated names] belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain. 
Zdravilo [Neurontin in povezana imena] sodi v skupino zdravil, ki jih uporabljamo za zdravljenje epilepsije in perifernih nevropatskih bolečin.
For anuric patients undergoing haemodialysis who have never received gabapentin, a loading dose of 300 to 400 mg, then 200 to 300 mg of gabapentin following each 4 hours of haemodialysis, is recommended. 
Pri anuričnih bolnikih na hemodializi, ki niso še dobivali gabapentina, je priporočljiv polnilni odmerek od 300 do 400 mg in nato od 200 do 300 mg gabapentina po vsakih 4 urah hemodialize.
Signs of acute toxicity in animals included ataxia, laboured breathing, ptosis, hypoactivity, or excitation. 
Med znaki akutne toksičnosti pri živalih so bile ataksija, težko dihanje, ptoza, hipoaktivnost ali vznemirjenost.
A clinical trial of adjunctive treatment of partial seizures in paediatric subjects, ranging in age from 3 to 12 years, showed a numerical but not statistically significant difference in the 50% responder rate in favour of the gabapentin group compared to placebo. 
Klinično preskušanje dopolnilnega zdravljenja parcialnih epileptičnih napadov pri pediatričnih preiskovancih, starih od 3 do 12 let, je pokazalo številsko, ne pa statistično značilne razlike pri 50odstotnem odzivu v prid skupine z gapabentinom v primerjavi s placebom.
AUC(0-8) = Steady state area under plasma concentration-time curve from time 0 to 8 hours postdose 
AUC(0-8) = površina pod krivuljo koncentracije po času v stanju dinamičnega ravnovesja od 0 do 8 ur po odmerku
Gabapentin did not increase the incidence of malformations, compared to controls, in the offspring of mice, rats, or rabbits at doses up to 50, 30 and 25 times respectively, the daily human dose of 3600 mg, (four, five or eight times, respectively, the human daily dose on a mg/m2 basis). 
Gabapentin v primerjavi s kontrolami ni povečal incidence malformacij pri potomstvu miši, podgan ali kuncev v do 50-, 30- in 25-kratnikih dnevnega odmerka 3600 mg pri človeku (kar je štirikratnik, petkratnik oz. osemkratnik dnevnega odmerka pri človeku na podlagi mg/m2).
What [Neurontin and associated names] is and what it is used for Before you take [Neurontin and associated names] How to take [Neurontin and associated names] Possible side effects 
Kaj je zdravilo [Neurontin in povezana imena] in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo [Neurontin in povezana imena] Kako jemati zdravilo [Neurontin in povezana imena] Možni neželeni učinki
• Allergic reaction such as hives 
• alergijska reakcija, npr. koprivnica
Pfizer Aps Lautrupvang 8 2750 Ballerup Denmark 
Pfizer Aps Lautrupvang 8 2750 Ballerup Danska
Also supplied as a titration pack for treatment of neuropathic pain containing 40 x 300 mg capsules and 10 x 600 mg tablets. 
Za zdravljenje nevropatskih bolečin je na voljo tudi titracijsko pakiranje s 40 x 300 mg kapsulami in 10 x 600 mg tabletami.
Gabapentin steady-state pharmacokinetics are similar for healthy subjects and patients with epilepsy receiving these antiepileptic agents. 
Farmakokinetika gabapentina v stanju dinamičnega ravnovesja je pri zdravih preiskovancih podobna kot pri bolnikih z epilepsijo, ki dobivajo ta antiepileptična zdravila.
Gabapentin slightly reduces the release of monoamine neurotransmitters in vitro. 
Gabapentin in vitro rahlo zmanjša sproščanje monoaminskih nevrotransmiterjev.
Gabapentin should not be used during pregnancy unless the potential benefit to the mother clearly outweighs the potential risk to the foetus. 
Gabapentin smete med nosečnostjo uporabiti le, če možna korist za mater jasno odtehta možno tveganje za plod.
Cmax = Maximum steady state plasma concentration tmax = Time for Cmax 
Cmax = največja koncentracija v plazmi v stanju dinamičnega ravnovesja tmax = čas do Cmax t1/2 = eliminacijski razpolovni čas
In patients with epilepsy, gabapentin concentrations in cerebrospinal fluid (CSF) are approximately 20% of corresponding steady-state trough plasma concentrations. 
Pri bolnikih z epilepsijo je koncentracija gabapentina v cerebrospinalnem likvorju približno 20 % ustrezne najmanjše plazemske koncentracije v stanju dinamičnega ravnovesja.
It is recommended that gabapentin be taken at the earliest two hours following antacid administration. 
Gabapentin je priporočljivo vzeti najmanj dve uri po uporabi antacida.
In vitro studies with radiolabeled gabapentin have characterized a novel peptide binding site in rat brain tissues including neocortex and hippocampus that may relate to anticonvulsant and analgesic activity of gabapentin and its structural derivatives. 
Študije in vitro z radioaktivno označenim gabapentinom so pokazale novo peptidno vezavno mesto v tkivu podganjih možganov, vključno z neokorteksom in hipokampusom, ki je morda povezano z antikonvulzivnim in analgetičnim delovanjem gabapentina in njegovih strukturnih izpeljank.
Gabapentin should be used in breast-feeding mothers only if the benefits clearly outweigh the risks. 
Gabapentin uporabite pri nosečih materah le, če je očitno, da koristi odtehtajo tveganja.
• Feeling tired, fever 
• občutek utrujenosti, zvišana telesna temperatura
False positive readings may be obtained in the semi-quantitative determination of total urine protein by dipstick tests. 
Pri semikvantitativnem določanju celotnih beljakovin v urinu s testnimi trakovi se lahko pojavijo lažno pozitivni izvidi.
How to store [Neurontin and associated names] Further information 
Shranjevanje zdravila [Neurontin in povezana imena] Dodatne informacije
Gabapentin does not interact with sodium channels in vitro and so differs from phenytoin and carbamazepine. 
Gabapentin in vitro ne interagira z natrijevimi kanali in se tako razlikuje od fenitoina in karbamazepina.
Slower titration of gabapentin dosage may be appropriate for individual patients. 
Za posamezne bolnike utegne biti primerno počasnejše titriranje odmerka gabapentina.
The elimination half-life of gabapentin is independent of dose and averages 5 to 7 hours. 
Njegov eliminacijski razpolovni čas ni odvisen od odmerka in v povprečju znaša od 5 do 7 ur.
In addition to the maintenance dose, an additional 200 to 300 mg dose following each 4-hour haemodialysis treatment is recommended. 
Poleg vzdrževalnega odmerka je priporočljiv dodaten odmerek od 200 do 300 mg po vsakih 4 urah hemodialize.
withdrawal reactions (mostly anxiety, insomnia, nausea, pains, sweating), chest pain. 
odtegnitvene reakcije (večinoma anksioznost, nespečnost, navzea, bolečine, znojenje), bolečine v prsih.
An increased incidence of hydroureter and/or hydronephrosis was observed in rats given 2000 mg/kg/day in a fertility and general reproduction study, 1500 mg/kg/day in a teratology study, and 500, 1000, and 2000 mg/kg/day in a perinatal and postnatal study. 
Večjo incidenco hidroureterja in/ali hidronefroze so opažali pri podganah, ki so dobivale 2000 mg/kg/dan v študiji plodnosti in splošne reprodukcije, 1500 mg/kg/dan v študiji teratogenosti ter 500, 1000 in 2000 mg/kg/dan v perinatalni in postnatalni študiji.
A variety of different diseases can cause peripheral (primarily occurring in the legs and/or arms) neuropathic pain, such as diabetes or shingles. 
Periferne nevropatske bolečine (ki se pojavljajo predvsem v nogah in/ali rokah) so lahko posledica najrazličnejših bolezni, npr. diabetesa in pasovca.
Gabapentin is structurally related to the neurotransmitter GABA (gamma-aminobutyric acid) but its mechanism of action is different from that of several other active substances that interact with GABA synapses including valproate, barbiturates, benzodiazepines, GABA transaminase inhibitors, GABA uptake inhibitors, GABA agonists, and GABA prodrugs. 
Gabapentin je po zgradbi soroden nevrotransmiterju GABA (gama-aminomaslena kislina), toda njegov mehanizem delovanja se razlikuje od mehanizma pri različnih drugih zdravilnih učinkovinah, ki vplivajo na sinapse GABA, vključno z valproatom, barbiturati, benzodiazepini, zaviralci GABA-transaminaze, zaviralci prevzema GABA, antagonisti GABA in predzdravili GABA.
In addition, the MAH confirmed the intention, in a letter of commitment, to submit across EU a paediatric liquid formulation in order to provide a dosage form more suitable for use in children. 
Poleg tega je imetnik dovoljenja za promet z zdravilom v pismu obveze potrdil namen, da bo po vsej EU predložil otroško tekočo obliko, da bo odmerjanje bolj primerno za otroke.
Gabapentin, the active substance of [Neurontin and associated names], is excreted in human milk. 
Gabapentin, zdravilna učinkovina v zdravilu [Neurontin in povezana imena], se izloča v materino mleko.
• Decreased platelets (blood clotting cells) 
• zmanjšano število trombocitov (krvnih ploščic, potrebnih za strjevanje krvi)
[Neurontin and associated names] should not be taken during pregnancy, unless you are told otherwise by your doctor. 
Zdravila [Neurontin in povezana imena] ne smete jemati med nosečnostjo, razen če vam tako naroči zdravnik.
Because the effect on the breast-fed infant is unknown, caution should be exercised when gabapentin is administered to a breast-feeding mother. 
Učinek na dojenega otroka ni znan, zato je treba gabapentin pri doječih materah uporabljati previdno.
6.3 Shelf life [To be completed nationally] 6.4 Special precautions for storage [To be completed nationally] 6.5 Nature and contents of container [To be completed nationally] Capsules: 20, 30, 50, 84, 90, 98, 100, 200, 500, 1000 Tablets: 20, 30, 45, 50, 84, 90, 100, 200, 500 
Kapsule: 20, 30, 50, 84, 90, 98, 100, 200, 500, 1000
• High blood pressure, flushing or dilation of blood vessels 
• visok krvni tlak, zardevanje ali razširitev žil
In general, plasma gabapentin concentrations in children > 5 years of age are similar to those in adults when dosed on a mg/kg basis. 
Na splošno je bila koncentracija gabapentina v plazmi ob odmerjanju na podlagi mg/kg pri otrocih, starejših od 5 let, podobna kot pri odraslih.